GPT and cardiovascular disorder: Since the discovery of serum aminotransferases in the early 1960s, serum aminotransferase levels, including serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), have been widely used as indicators of liver function and have also recently gained attention as emerging predictors of cardiovascular disease [1–4].